FDA Inspection 1218227 — Summit Biosciences Inc.
The FDA completed an inspection of Summit Biosciences Inc. on September 14, 2023 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 14, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Lexington, KY (United States)